Skip to main content
Figure 6 | BMC Cancer

Figure 6

From: Preoperative serum HER2 extracellular domain levels in primary invasive breast cancer

Figure 6

Distant-metastasis-free survival (DMFS) and breast-cancer-specific survival (BCSS) according to HER2 status in both tissue and serum. DMFS (A) and BCSS (B) among three subgroups classified according to both tissue and serum HER2 status: tissue– irrespective of serum status, tissue+/serum–, and tissue+/serum+. (C,D) There was a significant trend toward a reduction in survival with increasing serum HER2 ECD values in only 692 patients with a positive tissue HER2 status.

Back to article page